Cargando…
Alternative splicing and the progesterone receptor in breast cancer
Progesterone receptor status is a marker for hormone responsiveness and disease prognosis in breast cancer. Progesterone receptor negative tumours have generally been shown to have a poorer prognosis than progesterone receptor positive tumours. The observed loss of progesterone receptor could be thr...
Autores principales: | Cork, David MW, Lennard, Thomas WJ, Tyson-Capper, Alison J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481493/ https://www.ncbi.nlm.nih.gov/pubmed/18557990 http://dx.doi.org/10.1186/bcr2097 |
Ejemplares similares
-
Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance
por: Jackson, Claire, et al.
Publicado: (2013) -
HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes
por: Hart, Vic, et al.
Publicado: (2020) -
Alternative splicing: an important mechanism for myometrial gene regulation that can be manipulated to target specific genes associated with preterm labour
por: Tyson-Capper, Alison Jane
Publicado: (2007) -
Relationship between nucleosome positioning and progesterone-induced alternative splicing in breast cancer cells
por: Iannone, Camilla, et al.
Publicado: (2015) -
The Role of Progesterone Receptors in Breast Cancer
por: Li, Zhuo, et al.
Publicado: (2022)